Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches

Pharmacology and Therapeutics

Volumn 144, Issue 3, 2014, Pages 253-267

  Tousoulis, Dimitris ^a   Simopoulou, Chryssa ^a   Papageorgiou, Nikos ^a   Oikonomou, Evangelos ^a   Hatzis, George ^a   Siasos, Gerasimos ^a   Tsiamis, Eleftherios ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atherosclerosis; Cardiovascular disease; Endothelial function; Therapeutic approaches

Indexed keywords

ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE;

ANIMAL; ATHEROSCLEROSIS; DRUG EFFECTS; GENE THERAPY; HUMAN; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; GENETIC THERAPY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MICROCIRCULATION; NITRIC OXIDE; RENIN-ANGIOTENSIN SYSTEM; VASODILATION;

EID: 84908700894     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.06.003     Document Type: Review

References (272)

1. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360. (2002)., 23-33.
2. Effects of ramipril on cardiovascular andmicrovascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 355. (2000)., 253-259.
3. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354. (1999)., 447-455.
4. Abularrage, C. J., Sidawy, A. N., Aidinian, G., Singh, N., Weiswasser, J. M., & Arora, S. (2005). Evaluation of the microcirculation in vascular disease. J Vasc Surg 42, 574-581.
5. Alp, N. J., Mussa, S., Khoo, J., Cai, S., Guzik, T., Jefferson, A., et al. (2003). Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112, 725-735.
6. Anderson, T. J., Uehata, A., Gerhard, M.D., Meredith, I. T., Knab, S., Delagrange, D., et al. (1995). Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26, 1235-1241.
7. Antoniades, C., Antonopoulos, A. S., Bendall, J. K., & Channon, K. M. (2009). Targeting redox signaling in the vascular wall: from basic science to clinical practice. Curr Pharm Des 15, 329-342.
8. Antoniades, C., Antonopoulos, A. S., Tousoulis, D., Marinou, K., & Stefanadis, C. (2009). Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 30, 6-15.
9. Antoniades, C., Bakogiannis, C., Leeson, P., Guzik, T. J., Zhang, M. H., Tousoulis, D., et al. (2011). Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation 124, 335-345.
10. Antoniades, C., Shirodaria, C., Crabtree, M., Rinze, R., Alp, N., Cunnington, C., et al. (2007). Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation. Circulation 116, 2851-2859.
11. Antoniades, C., Shirodaria, C., Leeson, P., Antonopoulos, A., Warrick, N., Van-Assche, T., et al. (2009). Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J 30, 1142-1150.
12. Antoniades, C., Shirodaria, C., Warrick, N., Cai, S., de Bono, J., Lee, J., et al. (2006). 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114, 1193-1201.
13. Antoniades, C., Tousoulis, D., Marinou, K., Papageorgiou, N., Bosinakou, E., Tsioufis, C., et al. (2007). Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin Cardiol 30, 295-300.
14. Antoniades, C., Tousoulis, D., Marinou, K., Stefanadi, E., Ntarladimas, I., Latsios, G., et al. (2006). Effects of lipid profile on forearm hyperemic response in young subjects. Hellenic J Cardiol 47, 152-157.
15. Antoniades, C., Tousoulis, D., Tentolouris, C., Toutouza, M., Marinou, K., Goumas, G., et al. (2003). Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers. Thromb Haemost 89, 990-995.
16. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., et al. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85, 221-228.
17. Asselbergs, F. W., van der Harst, P., van Roon, A.M., Hillege, H. L., de Jong, P. E., Gans, R. O., et al. (2008). Long-termeffects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects. Atherosclerosis 196, 349-355.
18. Bank, A. J., Kelly, A. S., Thelen, A.M., Kaiser, D. R., & Gonzalez-Campoy, J. M. (2007). Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Hypertens 20, 777-783.
19. Baron, A.D., & Clark, M. G. (1997). Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr 17, 487-499.
20. Bauters, C., Asahara, T., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., et al. (1995). Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91, 2802-2809.
21. Beishuizen, E. D., Tamsma, J. T., Jukema, J. W., van de Ree, M.A., van der Vijver, J. C., Meinders, A. E., et al. (2005). The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease. Diabetes Care 28, 1668-1674.
22. Bellia, A., Rizza, S., Galli, A., Fabiano, R., Donadel, G., Lombardo, M. F., et al. (2010). Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. Atherosclerosis 210, 199-201.
23. Blann, A.D., Tse, W., Maxwell, S. J., & Waite, M.A. (1994). Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 12, 925-928.
24. Boger, R. H. (2006). Asymmetric dimethylarginine (ADMA): a novel riskmarker in cardiovascular medicine and beyond. Ann Med 38, 126-136.
25. Boger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2005). Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chem Lab Med 43, 1124-1129.
26. Bonetti, P. O., Pumper, G. M., Higano, S. T., Holmes, D. R., Jr., Kuvin, J. T., & Lerman, A. (2004). Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44, 2137-2141.
27. Boulanger, C. M., Amabile, N., & Tedgui, A. (2006). Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48, 180-186.
28. Brevetti, G., Silvestro, A., Schiano, V., & Chiariello, M. (2003). Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle- brachial pressure index. Circulation 108, 2093-2098.
29. Briasoulis, A., Tousoulis, D., Androulakis, E. S., Papageorgiou, N., Latsios, G., & Stefanadis, C. (2012). Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches. Recent Pat Cardiovasc Drug Discov 7, 21-32.
30. Brown, K. A., Chu, Y., Lund, D.D., Heistad, D.D., & Faraci, F. M. (2006). Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am J Physiol Heart Circ Physiol 290, H2600-H2605.
31. Caballero, A. E., Arora, S., Saouaf, R., Lim, S.C., Smakowski, P., Park, J. Y., et al. (1999). Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48, 1856-1862.
32. Caballero, A. E., Saouaf, R., Lim, S.C., Hamdy, O., Abou-Elenin, K., O'Connor, C., et al. (2003). The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism 52, 173-180.
33. Calnek, D. S., Mazzella, L., Roser, S., Roman, J., & Hart, C. M. (2003). Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 23, 52-57.
34. Carr, A.C., Zhu, B. Z., & Frei, B. (2000). Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 87, 349-354.
35. Celermajer, D. S. (1998). Testing endothelial function using ultrasound. J Cardiovasc Pharmacol 32(Suppl. 3), S29-S32.
36. Celermajer, D. S. (2005). Brachial artery FMD with 5-minute distal cuff occlusion - a useful pathophysiological test after all! J Appl Physiol 99(1985), 1619.
37. Celermajer, D. S., Sorensen, K. E., Bull, C., Robinson, J., & Deanfield, J. E. (1994). Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24, 1468-1474.
38. Ceriello, A., Taboga, C., Tonutti, L., Quagliaro, L., Piconi, L., Bais, B., et al. (2002). Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106, 1211-1218.
39. Chakrabarti, S., Blair, P., & Freedman, J. E. (2007). CD40-40L signaling in vascular inflammation. J Biol Chem 282, 18307-18317.
40. Chan, Y., Fish, J. E., D'Abreo, C., Lin, S., Robb, G. B., Teichert, A.M., et al. (2004). The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J Biol Chem 279, 35087-35100.
41. Chan, L., Shaw, A. G., Busfield, F., Haluska, B., Barnett, A., Kesting, J., et al. (2005). Carotid artery intimal medial thickness, brachial artery flow-mediated vasodilation and cardiovascular risk factors in diabetic and non-diabetic indigenous Australians. Atherosclerosis 180, 319-326.
42. Channon, K. M. (2004). Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 14, 323-327.
43. Channon, K. M., & Guzik, T. J. (2002). Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 53, 515-524.
44. Charakida, M., Masi, S., Luscher, T. F., Kastelein, J. J., & Deanfield, J. E. (2010). Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur Heart J 31, 2854-2861.
45. Chowienczyk, P. J., Kelly, R. P., MacCallum, H., Millasseau, S.C., Andersson, T. L., Gosling, R. G., et al. (1999). Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 34, 2007-2014.
46. Chowienczyk, P. J., Watts, G. F., Cockcroft, J. R., & Ritter, J. M. (1992). Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430-1432.
47. Chu, Y., Iida, S., Lund, D.D., Weiss, R. M., DiBona, G. F., Watanabe, Y., et al. (2003). Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 92, 461-468.
48. Cockcroft, J. R., Chowienczyk, P. J., Brett, S. E., Chen, C. P., Dupont, A. G., Van Nueten, L., et al. (1995). Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther 274, 1067-1071.
49. Cominacini, L., Fratta Pasini, A., Garbin, U., Nava, C., Davoli, A., Criscuoli, M., et al. (2003). Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. J Am Coll Cardiol 42, 1838-1844.
50. Corretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F., Creager, M.A., et al. (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39, 257-265.
51. Cousin, M., Custaud, M.A., Baron-Menguy, C., Toutain, B., Dumont, O., Guihot, A. L., et al. (2010). Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension 55, 109-115.
52. Csiszar, A., Labinskyy, N., Perez, V., Recchia, F. A., Podlutsky, A., Mukhopadhyay, P., et al. (2008). Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol 295, H1882-H1894.
53. Cui, B., Huang, L., Fang, Y., Guo, R., Yin, Y., & Zhao, X. (2011). Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation. Microvasc Res 81, 143-150.
54. Cunnington, C., & Channon, K. M. (2010). Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology. Heart 96, 1872-1877.
55. Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., et al. (1990). Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 87, 5134-5138.
56. Dai, D. F., Chen, T., Szeto, H., Nieves-Cintron, M., Kutyavin, V., Santana, L. F., et al. (2011). Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 58, 73-82.
57. De Caterina, R., Ghiadoni, L., Taddei, S., Virdis, A., Almerigogna, F., Basta, G., et al. (2001). Soluble E-selectin in essential hypertension: a correlate of vascular structural changes. Am J Hypertens 14, 259-266.
58. de Jongh, R. T., Serne, E. H., IJzerman, R. G., de Vries, G., & Stehouwer, C. D. (2004). Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109, 2529-2535.
59. Deanfield, J., Donald, A., Ferri, C., Giannattasio, C., Halcox, J., Halligan, S., et al. (2005). Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23, 7-17.
60. Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007). Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285-1295.
61. Degraeve, F., Bolla, M., Blaie, S., Creminon, C., Quere, I., Boquet, P., et al. (2001). Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. J Biol Chem 276, 46849-46855.
62. Dengel, D. R., Kelly, A. S., Steinberger, J., & Sinaiko, A.R. (2007). Effect of oral glucose loading on endothelial function in normal-weight and overweight children. Clin Sci (Lond) 112, 493-498.
63. DeSouza, C. A., Dengel, D. R., Macko, R. F., Cox, K., & Seals, D. R. (1997). Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens 10, 1335-1341.
64. Doshi, S. N., McDowell, I. F., Moat, S. J., Payne, N., Durrant, H. J., Lewis, M. J., et al. (2002). Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105, 22-26.
65. Drexler, H., Zeiher, A.M., Meinzer, K., & Just, H. (1991). Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 338, 1546-1550.
66. Duan, S. Z., Usher, M. G., & Mortensen, R. M. (2008). Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res 102, 283-294.
67. Dupuis, J., Tardif, J. C., Rouleau, J. L., Ricci, J., Arnold, M., Lonn, E., et al. (2005). Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial). Am J Cardiol 96, 1207-1213.
68. Epstein, S. E., Kornowski, R., Fuchs, S., & Dvorak, H. F. (2001). Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104, 115-119.
69. Erdos, E. G., Tan, F., & Skidgel, R. A. (2010). Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 55, 214-220.
70. Esposito, K., Ciotola, M., Giugliano, F., Schisano, B., Improta, L., Improta, M. R., et al. (2007). Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 19, 161-166.
71. Esposito, K., Ciotola, M., Schisano, B., Gualdiero, R., Sardelli, L., Misso, L., et al. (2006). Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab 91, 3676-3679.
72. Evangelista, S., Garbin, U., Pasini, A. F., Stranieri, C., Boccioletti, V., & Cominacini, L. (2007). Effect of DL-nebivolol, its enantiomers andmetabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells. Pharmacol Res 55, 303-309.
73. Faggiotto, A., & Paoletti, R. (1999). State-of-the-art lecture. Statins and blockers of the renin\angiotensin system: vascular protection beyond their primarymode of action. Hypertension 34, 987-996.
74. Fathi, R., Haluska, B., Isbel, N., Short, L., &Marwick, T. H. (2004). The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 43, 616-623.
75. Faulx, M.D., Wright, A. T., & Hoit, B.D. (2003). Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 145, 943-951.
76. Feng, M., He, Z. M., Zhu, Y. X., Liu, L. H., Lu, C. W., & Xiong, Y. (2010). Improvement of endothelial dysfunction in atherosclerotic rabbit aortas by ex vivo gene transferring of dimethylarginine dimethylaminohydrolase-2. Int J Cardiol 144, 180-186.
77. Fennell, J. P., Brosnan, M. J., Frater, A. J., Hamilton, C. A., Alexander, M. Y., Nicklin, S. A., et al. (2002). Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther 9, 110-117.
78. Feuerstein, G. Z., & Ruffolo, R. R., Jr. (1995). Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J 16(Suppl. F), 38-42.
79. Fichtlscherer, S., Breuer, S., & Zeiher, A.M. (2004). Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient. Circulation 110, 1926-1932.
80. Fish, J. E., Matouk, C. C., Rachlis, A., Lin, S., Tai, S.C., D'Abreo, C., et al. (2005). The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 280, 24824-24838.
81. Flammer, A. J., Sudano, I., Hermann, F., Gay, S., Forster, A., Neidhart, M., et al. (2008). Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation 117, 2262-2269.
82. Fratta Pasini, A., Garbin, U., Nava, M. C., Stranieri, C., Davoli, A., Sawamura, T., et al. (2005). Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. J Hypertens 23, 589-596.
83. Frei, B., Stocker, R., & Ames, B. N. (1988). Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 85, 9748-9752.
84. Frick, M., Suessenbacher, A., Alber, H. F., Dichtl, W., Ulmer, H., Pachinger, O., et al. (2005). Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol 46, 1006-1010.
85. Fu, Y. F., Xiong, Y., & Guo, Z. (2005). A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats. Eur J Pharmacol 508, 167-175.
86. Fukuda, Y., Teragawa, H., Matsuda, K., Yamagata, T., Matsuura, H., & Chayama, K. (2002). Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 87, 264-269.
87. Gates, P. E., Boucher, M. L., Silver, A. E., Monahan, K. D., & Seals, D. R. (2007). Impaired flow-mediated dilation with age is not explained by L -arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J Appl Physiol 102(1985), 63-71.
88. Gemici, B., Tan, R., Ongut, G., & Izgut-Uysal, V. N. (2010). Expressions of inducible nitric oxide synthase and cyclooxygenase-2 in gastric ischemia-reperfusion: role of angiotensin II. J Surg Res 161, 126-133.
89. Ghiadoni, L., Donald, A. E., Cropley, M., Mullen, M. J., Oakley, G., Taylor, M., et al. (2000). Mental stress induces transient endothelial dysfunction in humans. Circulation 102, 2473-2478.
90. Ghiadoni, L., Versari, D., Giannarelli, C., Faita, F., & Taddei, S. (2008). Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 14, 3715-3722.
91. Goldstein, J. L., & Brown, M. S. (1990). Regulation of themevalonate pathway. Nature 343, 425-430.
92. Goon, P. K., Boos, C. J., & Lip, G. Y. (2005). Circulating endothelial cells:markers of vascular dysfunction. Clin Lab 51, 531-538.
93. Graham, D., Huynh, N. N., Hamilton, C. A., Beattie, E., Smith, R. A., Cocheme, H. M., et al. (2009). Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54, 322-328.
94. Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000). NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86, 494-501.
95. Gush, R. J., & King, T. A. (1991). Discrimination of capillary and arterio-venular blood flow in skin by laser Doppler flowmetry. Med Biol Eng Comput 29, 387-392.
96. Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., et al. (2002). Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105, 1656-1662.
97. Guzik, T. J., West, N. E., Black, E., McDonald, D., Ratnatunga, C., Pillai, R., et al. (2000). Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 86, E85-E90.
98. Haendeler, J., Popp, R., Goy, C., Tischler, V., Zeiher, A.M., & Dimmeler, S. (2005). Cathepsin D and H2O2 stimulate degradation of thioredoxin-1: implication for endothelial cell apoptosis. J Biol Chem 280, 42945-42951.
99. Halcox, J. P., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M.A., et al. (2002). Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653-658.
100. Hayashi, T., Sumi, D., Juliet, P. A., Matsui-Hirai, H., Asai-Tanaka, Y., Kano, H., et al. (2004). Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits. Cardiovasc Res 61, 339-351.
101. Hayward, C. S., Kraidly, M., Webb, C. M., & Collins, P. (2002). Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol 40, 521-528.
102. Heffernan, K. S., Fahs, C. A., Ranadive, S. M., & Patvardhan, E. A. (2010). L-Arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging. J Cardiovasc Pharmacol Ther 15, 17-23.
103. Heitzer, T., Brockhoff, C., Mayer, B., Warnholtz, A., Mollnau, H., Henne, S., et al. (2000). Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 86, E36-E41.
104. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Munzel, T. (2001). Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673-2678.
105. Heller, R., Unbehaun, A., Schellenberg, B., Mayer, B., Werner-Felmayer, G., & Werner, E. R. (2001). L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276, 40-47.
106. Higashi, Y., Matsuoka, H., Umei, H., Sugano, R., Fujii, Y., Soga, J., et al. (2010). Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells. Am J Physiol Endocrinol Metab 298, E202-E209.
107. Higashi, Y., Sasaki, S., Nakagawa, K., Fukuda, Y., Matsuura, H., Oshima, T., et al. (2002). Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am J Hypertens 15, 326-332.
108. Hill, J. M., Zalos, G., Halcox, J. P., Schenke, W. H., Waclawiw, M.A., Quyyumi, A. A., et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348, 593-600.
109. Hokanson, D. E., Sumner, D. S., & Strandness, D. E., Jr. (1975). An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 22, 25-29.
110. Hollenberg, S. M., Klein, L. W., Parrillo, J. E., Scherer, M., Burns, D., Tamburro, P., et al. (2001). Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104, 3091-3096.
111. Holmes, D. I., & Zachary, I. (2005). The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol 6, 209.
112. Hong, S. J., Choi, S.C., Kim, J. S., Shim, W. J., Park, S. M., Ahn, C. M., et al. (2010). Low-dose versus moderate-dose atorvastatin after acutemyocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation. Heart 96, 756-764.
113. Hornig, B., Landmesser, U., Kohler, C., Ahlersmann, D., Spiekermann, S., Christoph, A., et al. (2001). Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103, 799-805.
114. Hugel, B., Martinez, M. C., Kunzelmann, C., & Freyssinet, J. M. (2005). Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20, 22-27.
115. Hwang, J., Kleinhenz, D. J., Lassegue, B., Griendling, K. K., Dikalov, S., & Hart, C. M. (2005). Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288, C899-C905.
116. Hyndman, M. E., Verma, S., Rosenfeld, R. J., Anderson, T. J., & Parsons, H. G. (2002). Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 282, H2167-H2172.
117. Iida, S., Chu, Y., Francis, J., Weiss, R. M., Gunnett, C. A., Faraci, F. M., et al. (2005). Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure. Am J Physiol Heart Circ Physiol 289, H525-H532.
118. Imanishi, T., Tsujioka, H., Ikejima, H., Kuroi, A., Takarada, S., Kitabata, H., et al. (2008). Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension 52, 563-572.
119. Inanc, M. T., Kalay, N., Heyit, T., Ozdogru, I., Kaya, M. G., Dogan, A., et al. (2010). Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behcet's disease. Echocardiography 27, 997-1003.
120. Irani, K. (2000). Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87, 179-183.
121. Ishigaki, Y., Oka, Y., & Katagiri, H. (2009). Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol 20, 363-369.
122. Ishii, H., Uchiyama, H., & Kazama, M. (1991). Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 65, 618-623.
123. Ito, A., Egashira, K., Narishige, T., Muramatsu, K., & Takeshita, A. (2001). Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension. Jpn Circ J 65, 775-778.
124. Jackson, S. M., Parhami, F., Xi, X. P., Berliner, J. A., Hsueh, W. A., Law, R. E., et al. (1999). Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol 19, 2094-2104.
125. Jahangir, E., Vita, J. A., Handy, D., Holbrook, M., Palmisano, J., Beal, R., et al. (2009). The effect of L-arginine and creatine on vascular function and homocysteine metabolism. Vasc Med 14, 239-248.
126. Jialal, I., Fuller, C. J., & Huet, B.A. (1995). The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 15, 190-198.
127. John, S., Schlaich, M., Langenfeld, M., Weihprecht, H., Schmitz, G., Weidinger, G., et al. (1998). Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation 98, 211-216.
128. Kals, J., Kampus, P., Kals, M., Pulges, A., Teesalu, R., & Zilmer, M. (2006). Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease. Atherosclerosis 185, 368-374.
129. Kampoli, A.M., Tousoulis, D., Tentolouris, C., & Stefanadis, C. (2012). Novel agents targeting nitric oxide. Curr Vasc Pharmacol 10, 61-76.
130. Kelly, T. K., De Carvalho, D.D., & Jones, P. A. (2010). Epigenetic modifications as therapeutic targets. Nat Biotechnol 28, 1069-1078.
131. Kelly, R. P., Gibbs, H. H., O'Rourke, M. F., Daley, J. E., Mang, K., Morgan, J. J., et al. (1990). Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 11, 138-144.
132. Khan, F., Elhadd, T. A., Greene, S. A., & Belch, J. J. (2000). Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 23, 215-220.
133. Khan, F., Patterson, D., Belch, J. J., Hirata, K., & Lang, C. C. (2008). Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin Sci (Lond) 115, 295-300.
134. Kong, D., Melo, L. G., Mangi, A. A., Zhang, L., Lopez-Ilasaca, M., Perrella, M.A., et al. (2004). Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109, 1769-1775.
135. Kovacs, I., Toth, J., Tarjan, J., & Koller, A. (2006). Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE. Eur J Heart Fail 8, 451-459.
136. Kruger, A., Stewart, J., Sahityani, R., O'Riordan, E., Thompson, C., Adler, S., et al. (2006). Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int 70, 157-164.
137. Kubli, S., Feihl, F., & Waeber, B. (2001). Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation. Clin Pharmacol Ther 69, 238-244.
138. Kullo, I. J., Mozes, G., Schwartz, R. S., Gloviczki, P., Crotty, T. B., Barber, D. A., et al. (1997). Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity. Circulation 96, 2254-2261.
139. Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., et al. (2000). The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6, 1004-1010.
140. Kuvin, J. T., Patel, A.R., Sliney, K. A., Pandian, N. G., Sheffy, J., Schnall, R. P., et al. (2003). Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 146, 168-174.
141. Kuzkaya, N., Weissmann, N., Harrison, D.G., & Dikalov, S. (2003). Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278, 22546-22554.
142. Landmesser, U., Hornig, B., & Drexler, H. (2004). Endothelial function: a critical determinant in atherosclerosis? Circulation 109, II27-II33.
143. Laufs, U., & Liao, J. K. (1998). Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem273, 24266-24271.
144. Lavi, R., Zhu, X. Y., Chade, A.R., Lin, J., Lerman, A., & Lerman, L. O. (2010). Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 30, 976-983.
145. Lee, R., Channon, K.M., & Antoniades, C. (2012). Therapeutic strategies targeting endothelial function in humans: clinical implications. Curr Vasc Pharmacol 10, 77-93.
146. Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., et al. (2007). Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691-703.
147. Lee, J. M., Wiesmann, F., Shirodaria, C., Leeson, P., Petersen, S. E., Francis, J. M., et al. (2008). Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging. Atherosclerosis 197, 951-958.
148. Leeson, C. P., Robinson, M., Francis, J. M., Robson, M.D., Channon, K. M., Neubauer, S., et al. (2006). Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. J Cardiovasc Magn Reson 8, 381-387.
149. Leeson, P., Thorne, S., Donald, A., Mullen, M., Clarkson, P., & Deanfield, J. (1997). Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 78, 22-27.
150. Leon, M. L., & Zuckerman, S. H. (2005). Gamma interferon: a central mediator in atherosclerosis. Inflamm Res 54, 395-411.
151. Lerman, A., Burnett, J. C., Jr., Higano, S. T., McKinley, L. J., & Holmes, D. R., Jr. (1998). Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97, 2123-2128.
152. Lerman, A., & Zeiher, A.M. (2005). Endothelial function: cardiac events. Circulation 111, 363-368.
153. Li, D., & Mehta, J. L. (2003). 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein-induced endothelial dysfunction. Endothelium 10, 17-21.
154. Libby, P., Ridker, P.M., & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation 105, 1135-1143.
155. Lip, G. Y., & Blann, A. (1997). von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34, 255-265.
156. Liu, X., Engelman, R. M., Rousou, J. A., Cordis, G. A., & Das, D. K. (1992). Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors. Cardiovasc Drugs Ther 6, 437-443.
157. Lu, C. W., Guo, Z., Feng, M., Wu, Z. Z., He, Z. M., & Xiong, Y. (2010). Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells. Atherosclerosis 209, 66-73.
158. Lund, D.D., Gunnett, C. A., Chu, Y., Brooks, R. M., Faraci, F. M., & Heistad, D.D. (2004). Gene transfer of extracellular superoxide dismutase improves relaxation of aorta after treatment with endotoxin. Am J Physiol Heart Circ Physiol 287, H805-H811.
159. Luscher, T. F., & Barton, M. (1997). Biology of the endothelium. Clin Cardiol 20 (II-3-10).
160. Maier, W., Cosentino, F., Lutolf, R. B., Fleisch, M., Seiler, C., Hess, O. M., et al. (2000). Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol 35, 173-178.
161. Mak, I. T., Freedman, A.M., Dickens, B. F., & Weglicki, W. B. (1990). Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol 40, 2169-2175.
162. Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J. M., et al. (2000). Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841-843.
163. Mancini, G. B., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., et al. (1996). Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 94, 258-265.
164. Mason, R. P., Kalinowski, L., Jacob, R. F., Jacoby, A.M., & Malinski, T. (2005). Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans. Circulation 112, 3795-3801.
165. Masuda, H., & Asahara, T. (2003). Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58, 390-398.
166. Matouk, C. C., & Marsden, P. A. (2008). Epigenetic regulation of vascular endothelial gene expression. Circ Res 102, 873-887.
167. Matsuno, H., Takei, M., Hayashi, H., Nakajima, K., Ishisaki, A., & Kozawa, O. (2004). Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries. J Cardiovasc Pharmacol 43, 333-340.
168. McFarlane, R., McCredie, R. J., Bonney, M.A., Molyneaux, L., Zilkens, R., Celermajer, D. S., et al. (1999). Angiotensin converting enzyme inhibition and arterial endothelial function in adults with Type 1 diabetes mellitus. Diabet Med 16, 62-66.
169. Mehta, J. L. (2003). Pleiotropic effects of statins: howimportant are they in the prevention of vascular disease? Endothelium 10, 3-4.
170. Mitchell, G. F., Vita, J. A., Larson, M. G., Parise, H., Keyes, M. J., Warner, E., et al. (2005). Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 112, 3722-3728.
171. Mullen, M. J., Clarkson, P., Donald, A. E., Thomson, H., Thorne, S. A., Powe, A. J., et al. (1998). Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. J Am Coll Cardiol 31, 1330-1335.
172. Mullen, M. J., Wright, D., Donald, A. E., Thorne, S., Thomson, H., & Deanfield, J. E. (2000). Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J Am Coll Cardiol 36, 410-416.
173. Nagamia, S., Pandian, A., Cheema, F., Natarajan, R., Khan, Q. A., Patel, A.D., et al. (2007). The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome. Prev Cardiol 10, 204-209.
174. Nichols, W. W., Denardo, S. J., Wilkinson, I. B., McEniery, C. M., Cockcroft, J., & O'Rourke, M. F. (2008). Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens (Greenwich) 10, 295-303.
175. Nickenig, G., & Harrison, D.G. (2002). The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation 105, 393-396.
176. Nishioka, K., Nakagawa, K., Umemura, T., Jitsuiki, D., Ueda, K., Goto, C., et al. (2007). Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy. Heart 93, 247-248.
177. Nohria, A., Gerhard-Herman, M., Creager, M.A., Hurley, S., Mitra, D., & Ganz, P. (2006). Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 101(1985), 545-548.
178. Nussberger, J., Aubert, J. F., Bouzourene, K., Pellegrin, M., Hayoz, D., & Mazzolai, L. (2008). Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension 51, 1306-1311.
179. Nystrom, T., Nygren, A., & Sjoholm, A. (2004). Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease. Am J Physiol Endocrinol Metab 287, E919-E925.
180. O'Driscoll, G., Green, D., Maiorana, A., Stanton, K., Colreavy, F., & Taylor, R. (1999). Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 33, 1506-1511.
181. O'Driscoll, G., Green, D., & Taylor, R. R. (1997). Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95, 1126-1131.
182. Oelze, M., Daiber, A., Brandes, R. P., Hortmann, M., Wenzel, P., Hink, U., et al. (2006). Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48, 677-684.
183. Padayatty, S. J., Katz, A., Wang, Y., Eck, P., Kwon, O., Lee, J. H., et al. (2003). Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 22, 18-35.
184. Panza, J. A., Quyyumi, A. A., Brush, J. E., Jr., & Epstein, S. E. (1990). Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323, 22-27.
185. Papamichael, C. M., Aznaouridis, K. A., Karatzis, E. N., Karatzi, K. N., Stamatelopoulos, K. S., Vamvakou, G., et al. (2005). Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond) 109, 55-60.
186. Parthasarathy, S., Santanam, N., & Auge, N. (1998). Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease? Biochem Pharmacol 56, 279-284.
187. Pasceri, V., Wu, H. D., Willerson, J. T., & Yeh, E. T. (2000). Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101, 235-238.
188. Pasini, A. F., Garbin, U., Stranieri, C., Boccioletti, V., Mozzini, C., Manfro, S., et al. (2008). Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients. Am J Hypertens 21, 1251-1257.
189. Perticone, F., Ceravolo, R., Maio, R., Cloro, C., Candigliota, M., Scozzafava, A., et al. (2000). Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Atherosclerosis 152, 511-518.
190. Perticone, F., Ceravolo, R., Pujia, A., Ventura, G., Iacopino, S., Scozzafava, A., et al. (2001). Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104, 191-196.
191. Pirro, M., Schillaci, G., Romagno, P. F., Mannarino, M. R., Bagaglia, F., Razzi, R., et al. (2009). Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J Cardiovasc Pharmacol Ther 14, 14-21.
192. Qin, Z., Reszka, K. J., Fukai, T., & Weintraub, N. L. (2008). Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl Res 151, 68-78.
193. Rajagopalan, S., Shah, M., Luciano, A., Crystal, R., & Nabel, E. G. (2001). Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation 104, 753-755.
194. Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A.M., et al. (1990). Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, 254-257.
195. Reaven, P. D., Khouw, A., Beltz, W. F., Parthasarathy, S., & Witztum, J. L. (1993). Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb 13, 590-600.
196. Recchioni, R., Marcheselli, F., Moroni, F., & Pieri, C. (2002). Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L-cysteine. Metabolism 51, 1384-1388.
197. Rossi, M., Carpi, A., Di Maria, C., Franzoni, F., Galetta, F., & Santoro, G. (2009). Skin blood flowmotion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol Res 58, 39-47.
198. Schachinger, V., Britten, M. B., & Zeiher, A.M. (2000). Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899-1906.
199. Schindler, T. H., Hornig, B., Buser, P. T., Olschewski, M., Magosaki, N., Pfisterer, M., et al. (2003). Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol 23, 495-501.
200. Settergren, M., Pernow, J., Brismar, K., Jorneskog, G., & Kalani, M. (2008). Endothelin-A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy. J Vasc Res 45, 295-302.
201. Sharif, F., Hynes, S. O., Cooney, R., Howard, L., McMahon, J., Daly, K., et al. (2008). Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Ther 16, 1674-1680.
202. Shimbo, D., Grahame-Clarke, C., Miyake, Y., Rodriguez, C., Sciacca, R., Di Tullio, M., et al. (2007). The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 192, 197-203.
203. Siasos, G., Tousoulis, D., Michalea, S., Oikonomou, E., Kolia, C., Kioufis, S., et al. (2012). Biomarkers determining cardiovascular risk in patients with kidney disease. Curr Med Chem 19, 2555-2571.
204. Siekmeier, R., Steffen, C., & Marz, W. (2007). Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations. J Cardiovasc Pharmacol Ther 12, 265-282.
205. Smith, R. S., Jr., Agata, J., Xia, C. F., Chao, L., & Chao, J. (2005). Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 76, 2457-2471.
206. Smith, R. S., Jr., Lin, K. F., Agata, J., Chao, L., & Chao, J. (2002). Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler Thromb Vasc Biol 22, 1279-1285.
207. Staessen, J. A., Li, Y., & Richart, T. (2006). Oral renin inhibitors. Lancet 368, 1449-1456.
208. Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A.D. (1996). Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97, 2601-2610.
209. Stroes, E. S., van Faassen, E. E., Yo, M., Martasek, P., Boer, P., Govers, R., et al. (2000). Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 86, 1129-1134.
210. Sun, D., Huang, A., Smith, C. J., Stackpole, C. J., Connetta, J. A., Shesely, E. G., et al. (1999). Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res 85, 288-293.
211. Sun, W., Lee, T. S., Zhu, M., Gu, C., Wang, Y., Zhu, Y., et al. (2006). Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114, 2655-2662.
212. Suwaidi, J. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., Jr., & Lerman, A. (2000). Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101, 948-954.
213. Takeshita, S., Isshiki, T., Ochiai, M., Eto, K., Mori, H., Tanaka, E., et al. (1998). Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 98, 1261-1263.
214. Tamai, O., Matsuoka, H., Itabe, H., Wada, Y., Kohno, K., & Imaizumi, T. (1997). Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95, 76-82.
215. Tamaki, N., Takahashi, N., Kawamoto, M., Torizuka, T., Tadamura, E., Yonekura, Y., et al. (1994). Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 35, 594-600.
216. Tan, K. C., Chow, W. S., Tam, S.C., Ai, V. H., Lam, C. H., & Lam, K. S. (2002). Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 87, 563-568.
217. Taneva, E., Borucki, K., Wiens, L., Makarova, R., Schmidt-Lucke, C., Luley, C., et al. (2006). Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal. Am J Cardiol 97, 1002-1006.
218. Targonski, P. V., Bonetti, P. O., Pumper, G. M., Higano, S. T., Holmes, D. R., Jr., & Lerman, A. (2003). Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 107, 2805-2809.
219. ter Avest, E., Abbink, E. J., Holewijn, S., de Graaf, J., Tack, C. J., & Stalenhoef, A. F. (2005). Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH). Curr Med Res Opin 21, 1469-1476.
220. Thum, T., Fleissner, F., Klink, I., Tsikas, D., Jakob, M., Bauersachs, J., et al. (2007). Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. J Clin Endocrinol Metab 92, 4172-4179.
221. Torondel, B., Nandi, M., Kelly, P., Wojciak-Stothard, B., Fleming, I., & Leiper, J. (2010). Adenoviral-mediated overexpression of DDAH improves vascular tone regulation. Vasc Med 15, 205-213.
222. Tousoulis, D., Antoniades, C., Bosinakou, E., Kotsopoulou, M., Pitsavos, C., Vlachopoulos, C., et al. (2005a). Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. Atherosclerosis 178, 359-363.
223. Tousoulis, D., Antoniades, C., Bosinakou, E., Kotsopoulou, M., Tsioufis, C., Tentolouris, C., et al. (2005b). Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure. Heart 91, 27-31.
224. Tousoulis, D., Antoniades, C., Katsi, V., Bosinakou, E., Kotsopoulou, M., Tsioufis, C., et al. (2006). The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level. Int J Cardiol 109, 48-52.
225. Tousoulis, D., Antoniades, C., Koumallos, N., Marinou, K., Stefanadi, E., Latsios, G., et al. (2006). Novel therapies targeting vascular endothelium. Endothelium 13, 411-421.
226. Tousoulis, D., Antoniades, C., & Stefanadis, C. (2005). Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart 91, 553-558.
227. Tousoulis, D., Antoniades, C., & Stefanadis, C. (2006). Statins and antioxidant vitamins: should co-administration be avoided? J Am Coll Cardiol 47, 1237 (author reply 1237-1238).
228. Tousoulis, D., Antoniades, C., Tentolouris, C., Tsioufis, C., Toutouza, M., Toutouzas, P., et al. (2003). Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 170, 261-267.
229. Tousoulis, D., Antoniades, C., Tountas, C., Bosinakou, E., Kotsopoulou, M., Toutouzas, P., et al. (2003). Vitamin C affects thrombosis/fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease. Diabetes Care 26, 2749-2753.
230. Tousoulis, D., Antoniades, C., Vassiliadou, C., Toutouza, M., Pitsavos, C., Tentolouris, C., et al. (2005). Effects of combined administration of lowdose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure. Eur J Heart Fail 7, 1126-1132.
231. Tousoulis, D., Charakida, M., & Stefanadis, C. (2006). Endothelial function and inflammation in coronary artery disease. Heart 92, 441-444.
232. Tousoulis, D., Crake, T., Kaski, J. C., Rosen, S. D., Haider, A. W., & Davies, G. J. (1995). Enhanced vasomotor responses of complex coronary stenoses to acetylcholine in stable angina pectoris. Am J Cardiol 75, 725-728.
233. Tousoulis, D., & Davies, G. (1998). Acetylcholine and endothelial function. Circulation 98, 1588-1589.
234. Tousoulis, D., Davies, G., Lefroy, D. C., Haider, A. W., & Crake, T. (1996). Variable coronary vasomotor responses to acetylcholine in patientswith normal coronary arteriograms: evidence for localised endothelial dysfunction. Heart 75, 261-266.
235. Tousoulis, D., Kampoli, A.M., Papageorgiou, N., Androulakis, E., Antoniades, C., Toutouzas, K., et al. (2011). Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Des 17, 4089-4110.
236. Tousoulis, D., Kampoli, A.M., Tentolouris, C., Papageorgiou, N., & Stefanadis, C. (2012). The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10, 4-18.
237. Tousoulis, D., Koutsogiannis, M., Papageorgiou, N., Siasos, G., Antoniades, C., Tsiamis, E., et al. (2010). Endothelial dysfunction: potential clinical implications. Minerva Med 101, 271-284.
238. Tousoulis, D., Papageorgiou, N., Androulakis, E., Paroutoglou, K., & Stefanadis, C. (2010). Novel therapeutic strategies targeting vascular endothelium in essential hypertension. Expert Opin Investig Drugs 19, 1395-1412.
239. Tousoulis, D., Tentolouris, C., Crake, T., Toutouzas, P., & Davies, G. (1997). Basal and flow-mediated nitric oxide production by atheromatous coronary arteries. J Am Coll Cardiol 29, 1256-1262.
240. Trevelyan, J., Needham, E.W., Morris, A., & Mattu, R. K. (2005). Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. Heart 91, 1053-1057.
241. Vallance, P., & Leiper, J. (2004). Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24, 1023-1030.
242. Vassalli, G., Gallino, A., Kiowski, W., Jiang, Z., Turina, M., & Hess, O. M. (1997). Reduced coronary flow reserve during exercise in cardiac transplant recipients. Circulation 95, 607-613.
243. Verhaar, M. C., Wever, R. M., Kastelein, J. J., van Loon, D., Milstien, S., Koomans, H. A., et al. (1999). Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation 100, 335-338.
244. Versari, D., Lerman, L. O., & Lerman, A. (2007). The importance of reendothelialization after arterial injury. Curr Pharm Des 13, 1811-1824.
245. Virdis, A., Ghiadoni, L., & Taddei, S. (2011). Effects of antihypertensive treatment on endothelial function. Curr Hypertens Rep 13, 276-281.
246. Vita, J. A. (2002). Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol 359, 186-200.
247. Vlot, A. J., Koppelman, S. J., Bouma, B. N., & Sixma, J. J. (1998). Factor VIII and von Willebrand factor. Thromb Haemost 79, 456-465.
248. Vora, D. K., Fang, Z. T., Liva, S. M., Tyner, T. R., Parhami, F., Watson, A.D., et al. (1997). Induction of P-selectin by oxidized lipoproteins. Separate effects on synthesis and surface expression. Circ Res 80, 810-818.
249. Wagner, A. H., Kohler, T., Ruckschloss, U., Just, I., & Hecker, M. (2000). Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20, 61-69.
250. Wald, D. S., Law, M., & Morris, J. K. (2002). Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202.
251. Warnholtz, A., Nickenig, G., Schulz, E., Macharzina, R., Brasen, J. H., Skatchkov, M., et al. (1999). Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99, 2027-2033.
252. Wassmann, S., Laufs, U., Baumer, A. T., Muller, K., Konkol, C., Sauer, H., et al. (2001). Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 59, 646-654.
253. Wassmann, S., & Nickenig, G. (2003). Interrelationship of free oxygen radicals and endothelial dysfunction-modulation by statins. Endothelium 10, 23-33.
254. Watanabe, Y., Sunayama, S., Shimada, K., Sawano, M., Hoshi, S., Iwama, Y., et al. (2000). Troglitazone improves endothelial dysfunction in patients with insulin resistance. J Atheroscler Thromb 7, 159-163.
255. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., et al. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353, 999-1007.
256. Wheeler-Jones, C., Abu-Ghazaleh, R., Cospedal, R., Houliston, R. A., Martin, J., & Zachary, I. (1997). Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett 420, 28-32.
257. Widlansky, M. E., Gokce, N., Keaney, J. F., Jr., & Vita, J. A. (2003). The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42, 1149-1160.
258. Wiesmann, F., Petersen, S. E., Leeson, P.M., Francis, J. M., Robson, M.D., Wang, Q., et al. (2004). Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol 44, 2056-2064.
259. Wilkinson, I. B., Hall, I. R., MacCallum, H., Mackenzie, I. S., McEniery, C. M., van der Arend, B. J., et al. (2002). Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22, 147-152.
260. Wilkinson, I. B., MacCallum, H., Cockcroft, J. R., & Webb, D. J. (2002). Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 53, 189-192.
261. Wilkinson, I. B., & McEniery, C. M. (2004). Arterial stiffness, endothelial function and novel pharmacological approaches. Clin Exp Pharmacol Physiol 31, 795-799.
262. Wolfrum, S., Jensen, K. S., & Liao, J. K. (2003). Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 23, 729-736.
263. Woo, K. S., Chook, P., Yu, C. W., Sung, R. Y., Qiao, M., Leung, S. S., et al. (2004). Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 109, 1981-1986.
264. Woodcock, J. P. (1985). Noninvasive blood flow measurement. Crit Rev Biomed Eng 12, 201-235.
265. Yan, M. S., Matouk, C. C., & Marsden, P. A. (2010). Epigenetics of the vascular endothelium. J Appl Physiol 109(1985), 916-926.
266. Yokoyama, I., Negita, M., Liu, D.G., Nagasaka, T., Kobayashi, T., Hayakawa, A., et al. (2002). Prevention of free-radical induced apoptosis by induction of human recombinant Cu, Zn-SOD in pig endothelial cells. Transpl Int 15, 220-225.
267. Yoshida, O., Kondo, T., Kureishi-Bando, Y., Sugiura, T., Maeda, K., Okumura, K., et al. (2010). Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers. Circ J 74, 195-202.
268. Zeibig, S., Li, Z., Wagner, S., Holthoff, H. P., Ungerer, M., Bultmann, A., et al. (2011). Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ Res 108, 695-703.
269. Zhang, M. X., Ou, H., Shen, Y. H., Wang, J., Coselli, J., & Wang, X. L. (2005). Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci U S A 102, 16967-16972.
270. Zhang, D., Xie, X., Chen, Y., Hammock, B.D., Kong, W., & Zhu, Y. (2012). Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Circ Res 110, 808-817.
271. Zhang, M. X., Zhang, C., Shen, Y. H., Wang, J., Li, X. N., Chen, L., et al. (2008). Effect of 27 nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell 19, 3997-4005.
272. Zheng, J. S., Yang, X. Q., Lookingland, K. J., Fink, G. D., Hesslinger, C., Kapatos, G., et al. (2003). Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108, 1238-1245.